Dasatinib 50 mg Tablets

Get a Price/Quote

MOQ : 100 Packs

Dasatinib 50 mg Tablets Specification

Salt Composition
Dasatinib 50 mg

Indication
Treatment of chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (Ph+ ALL)

Dosage Form
Tablet

Feature
Prescription only, film-coated, potent tyrosine kinase inhibitor

Ingredients
Dasatinib and excipients

Application
Oral administration for cancer therapy

Physical Color/Texture
White to off-white, film-coated tablet

Fermentation Smell
Odorless

Storage Instructions
Store below 30C, protect from moisture and light

Shelf Life
24 months

Packaging Type
Blister pack or HDPE bottle

Therapeutic Class
Antineoplastic

ATC Code
L01XE06

Prescription Status
Prescription required

Route of Administration
Oral

Packaging Size
60 tablets per bottle/box

Strength
50 mg per tablet

Regulatory Approval
Marketed under applicable regulatory approvals (e.g. FDA, EMA, DCGI)

Side Effects
May include myelosuppression, fluid retention, diarrhea, skin rashes

Warning
Do not use in pregnancy; consult doctor before initiating therapy

Precautions
Use only under supervision of healthcare professional

Dasatinib 50 mg Tablets Trade Information

Minimum Order Quantity
100 Packs

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Packs Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

About Dasatinib 50 mg Tablets

Experience the spectacular efficacy of Dasatinib 50 mg Tablets-now at a reduced price for a limited time. With a ravishing focus on patient health, each bottle contains 60 fresh, film-coated tablets, providing a towering defense against chronic myeloid leukemia (CML) and Ph+ acute lymphoblastic leukemia (ALL). Carefully reserved for prescription use, these odorless, white-to-off-white tablets deliver potent antineoplastic activity through advanced tyrosine kinase inhibition. Available via trusted suppliers and traders across India, Dasatinib ensures secure storage, regulatory compliance, and peace of mind for healthcare professionals and patients alike.

Targeted Application: Cancer Therapy Excellence

Dasatinib 50 mg Tablets are engineered for oral cancer therapy, reserved specifically for the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). Its strong therapeutic profile makes it a preferred choice in hospitals, specialty clinics, and oncology centers. With proven effectiveness in hematological malignancies, it supports physicians and patients on their challenging treatment journeys, ensuring reliable results under strict medical supervision.

Efficient Supply & Secure Payment Options

Estimate your supply needs and benefit from prompt delivery of Dasatinib 50 mg Tablets through reputable transport services. Each dispatch is accompanied by essential certifications (FDA, EMA, DCGI) ensuring global quality standards. Suppliers in India guarantee robust supply ability, timely delivery, and transparent payment terms for effortless procurement. Every batch is delivered with care, safeguarding product integrity from warehouse to treatment facility.

FAQ's of Dasatinib 50 mg Tablets:

Q: How should Dasatinib 50 mg Tablets be stored for optimal effectiveness?

A: Dasatinib 50 mg Tablets should be stored below 30C, protected from moisture and light, to maintain their stability and potency throughout the 24-month shelf life.

Q: What are the main indications for prescribing Dasatinib 50 mg Tablets?

A: Dasatinib 50 mg Tablets are primarily indicated for the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) as part of an antineoplastic therapy regimen.

Q: When should therapy with Dasatinib 50 mg Tablets be avoided?

A: Therapy should not be initiated during pregnancy, and patients must consult their doctor before starting treatment. Use is restricted to supervision by a qualified healthcare professional.

Q: Where can Dasatinib 50 mg Tablets be obtained?

A: Dasatinib 50 mg Tablets are available through licensed suppliers and traders in India, provided only on prescription as per regulatory requirements such as FDA, EMA, or DCGI approval.

Q: What precautions should be observed during the use of Dasatinib 50 mg Tablets?

A: It is vital to use Dasatinib exclusively under medical supervision due to potential side effects such as myelosuppression, fluid retention, diarrhea, and skin rashes. Regular monitoring by a healthcare professional is necessary.

Tell us about your requirement